AIMS/HYPOTHESIS: Mutations in the hepatocyte nuclear factor 1-alpha gene (HNF-1alpha, now known as the transcription factor 1 gene [TCF1]) cause the most common monogenic form of diabetes, MODY3, but it is not known if common variants in HNF-1a are associated with decreased transcriptional activity or phenotypes related to type 2 diabetes, or whether they predict future type 2 diabetes. SUBJECTS AND METHODS: We studied the effect of four common polymorphisms (rs1920792, I27L, A98V and S487N) in and upstream of the HNF-1alpha gene on transcriptional activity in vitro, and their possible association with type 2 diabetes and insulin secretion in vivo. RESULTS: Certain combinations of the I27L and A98V polymorphisms in the HNF-1alpha gene showed decreased transcriptional activity on the target promoters glucose transporter 2 (now known as solute carrier family 2 [facilitated glucose transporter], member 2) and albumin in both HeLa and INS-1 cells. In vivo, these polymorphisms were associated with a modest but significant impairment in insulin secretion in response to oral glucose. Insulin secretion deteriorated over time in individuals carrying the V allele of the A98V polymorphism (n = 2,293; p = 0.003). In a new case-control (n = 1,511 and n = 2,225 respectively) data set, the I27L polymorphism was associated with increased risk of type 2 diabetes, odds ratio (OR) = 1.5 (p = 0.002; multiple logistic regression), particularly in elderly (age > 60 years) and overweight (BMI > 25 kg/m(2)) patients (OR = 2.3, p = 0.002). CONCLUSIONS/ INTERPRETATION: This study provides in vitro and in vivo evidence that common variants in the MODY3 gene, HNF-1alpha, influence transcriptional activity and insulin secretion in vivo. These variants are associated with a modestly increased risk of late-onset type 2 diabetes in subsets of elderly overweight individuals.
AIMS/HYPOTHESIS: Mutations in the hepatocyte nuclear factor 1-alpha gene (HNF-1alpha, now known as the transcription factor 1 gene [TCF1]) cause the most common monogenic form of diabetes, MODY3, but it is not known if common variants in HNF-1a are associated with decreased transcriptional activity or phenotypes related to type 2 diabetes, or whether they predict future type 2 diabetes. SUBJECTS AND METHODS: We studied the effect of four common polymorphisms (rs1920792, I27L, A98V and S487N) in and upstream of the HNF-1alpha gene on transcriptional activity in vitro, and their possible association with type 2 diabetes and insulin secretion in vivo. RESULTS: Certain combinations of the I27L and A98V polymorphisms in the HNF-1alpha gene showed decreased transcriptional activity on the target promoters glucose transporter 2 (now known as solute carrier family 2 [facilitated glucose transporter], member 2) and albumin in both HeLa and INS-1 cells. In vivo, these polymorphisms were associated with a modest but significant impairment in insulin secretion in response to oral glucose. Insulin secretion deteriorated over time in individuals carrying the V allele of the A98V polymorphism (n = 2,293; p = 0.003). In a new case-control (n = 1,511 and n = 2,225 respectively) data set, the I27L polymorphism was associated with increased risk of type 2 diabetes, odds ratio (OR) = 1.5 (p = 0.002; multiple logistic regression), particularly in elderly (age > 60 years) and overweight (BMI > 25 kg/m(2)) patients (OR = 2.3, p = 0.002). CONCLUSIONS/ INTERPRETATION: This study provides in vitro and in vivo evidence that common variants in the MODY3 gene, HNF-1alpha, influence transcriptional activity and insulin secretion in vivo. These variants are associated with a modestly increased risk of late-onset type 2 diabetes in subsets of elderly overweight individuals.
Authors: Steven Wiltshire; Timothy M Frayling; Christopher J Groves; Jonathan C Levy; Graham A Hitman; Mike Sampson; Mark Walker; Stephan Menzel; Andrew T Hattersley; Lon R Cardon; Mark I McCarthy Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Roland Perfekt; Kaj Lahti; Michael Nissén; Bo Isomaa; Björn Forsen; Nils Homström; Carola Saloranta; Marja-Riitta Taskinen; Leif Groop; Tiinamaija Tuomi Journal: Diabetes Date: 2005-01 Impact factor: 9.461
Authors: M Vaxillaire; A Abderrahmani; P Boutin; B Bailleul; P Froguel; M Yaniv; M Pontoglio Journal: J Biol Chem Date: 1999-12-10 Impact factor: 5.157
Authors: M M Mahtani; E Widén; M Lehto; J Thomas; M McCarthy; J Brayer; B Bryant; G Chan; M Daly; C Forsblom; T Kanninen; A Kirby; L Kruglyak; K Munnelly; M Parkkonen; M P Reeve-Daly; A Weaver; T Brettin; G Duyk; E S Lander; L C Groop Journal: Nat Genet Date: 1996-09 Impact factor: 38.330
Authors: G Berglund; P Nilsson; K F Eriksson; J A Nilsson; B Hedblad; H Kristenson; F Lindgärde Journal: J Intern Med Date: 2000-01 Impact factor: 8.989
Authors: Inga Reynisdottir; Gudmar Thorleifsson; Rafn Benediktsson; Gunnar Sigurdsson; Valur Emilsson; Anna Sigurlin Einarsdottir; Eyrun Edda Hjorleifsdottir; Gudbjorg Th Orlygsdottir; Gudrun Thora Bjornsdottir; Jona Saemundsdottir; Skarphedinn Halldorsson; Soffia Hrafnkelsdottir; Steinunn Bjorg Sigurjonsdottir; Svana Steinsdottir; Mitchell Martin; Jarema P Kochan; Brian K Rhees; Struan F A Grant; Michael L Frigge; Augustine Kong; Vilmundur Gudnason; Kari Stefansson; Jeffrey R Gulcher Journal: Am J Hum Genet Date: 2003-07-08 Impact factor: 11.025
Authors: S A Urhammer; A M Møller; B Nyholm; C T Ekstrøm; H Eiberg; J O Clausen; T Hansen; O Pedersen; O Schmitz Journal: J Clin Endocrinol Metab Date: 1998-11 Impact factor: 5.958
Authors: Jason W Hoskins; Jinping Jia; Marta Flandez; Hemang Parikh; Wenming Xiao; Irene Collins; Mickey A Emmanuel; Abdisamad Ibrahim; John Powell; Lizhi Zhang; Nuria Malats; William R Bamlet; Gloria M Petersen; Francisco X Real; Laufey T Amundadottir Journal: Carcinogenesis Date: 2014-09-18 Impact factor: 4.944
Authors: Donghui Li; Eric J Duell; Kai Yu; Harvey A Risch; Sara H Olson; Charles Kooperberg; Brian M Wolpin; Li Jiao; Xiaoqun Dong; Bill Wheeler; Alan A Arslan; H Bas Bueno-de-Mesquita; Charles S Fuchs; Steven Gallinger; Myron Gross; Patricia Hartge; Robert N Hoover; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Margaret T Mandelson; Gloria Petersen; Wei Zheng; Ilir Agalliu; Demetrius Albanes; Marie-Christine Boutron-Ruault; Paige M Bracci; Julie E Buring; Federico Canzian; Kenneth Chang; Stephen J Chanock; Michelle Cotterchio; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Judith A Hoffman Bolton; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Mazda Jenab; Kay-Tee Khaw; Peter Kraft; Vittorio Krogh; Robert C Kurtz; Robert R McWilliams; Julie B Mendelsohn; Alpa V Patel; Kari G Rabe; Elio Riboli; Xiao-Ou Shu; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Jarmo Virtamo; Kala Visvanathan; Joanne Watters; Herbert Yu; Anne Zeleniuch-Jacquotte; Laufey Amundadottir; Rachael Z Stolzenberg-Solomon Journal: Carcinogenesis Date: 2012-04-20 Impact factor: 4.944
Authors: Alexander P Reiner; Mathew J Barber; Yongtao Guan; Paul M Ridker; Leslie A Lange; Daniel I Chasman; Jeremy D Walston; Gregory M Cooper; Nancy S Jenny; Mark J Rieder; J Peter Durda; Joshua D Smith; John Novembre; Russell P Tracy; Jerome I Rotter; Matthew Stephens; Deborah A Nickerson; Ronald M Krauss Journal: Am J Hum Genet Date: 2008-04-24 Impact factor: 11.025
Authors: A M Farrelly; H Wobser; C Bonner; S Anguissola; M Rehm; C G Concannon; J H M Prehn; M M Byrne Journal: Diabetologia Date: 2008-10-24 Impact factor: 10.122
Authors: J Holmkvist; D Tojjar; P Almgren; V Lyssenko; C M Lindgren; B Isomaa; T Tuomi; G Berglund; E Renström; L Groop Journal: Diabetologia Date: 2007-10-13 Impact factor: 10.122
Authors: Fernando M A Giuffrida; Gilberto K Furuzawa; Teresa S Kasamatsu; Marcos M Oliveira; Andre F Reis; Sergio A Dib Journal: Cardiovasc Diabetol Date: 2009-06-02 Impact factor: 9.951